COMPANY

Intrinsic LifeSciences

HQ: La Jolla, CA source · intrinsiclifesciences.com ↗ · West Coast

Keywords: diagnostics Iron Deficiency Anemia

Location: La Jolla, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)13NIH grants

Timeline

Jun 30, 2016 Trial start —: Serum Hepcidin Immunoassay - Laboratory to Marketplace source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT03310736	Serum Hepcidin Immunoassay - Laboratory to Marketplace	Not listed	Completed	Jun 30, 2016	Dec 31, 2018 (actual)

NIH awards 13

Annual award amounts. Total $10.0M.

Aug 9, 2023 NIH award 5R44DK135139-02 FY2023: $788,664 awarded for that fiscal year; activity R44 (SBIR); PI OSTLAND, VAUGHN E; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Novel Point-of-Care Device for Urin source ↗
Sep 23, 2022 NIH award 1R44DK135139-01 FY2022: $960,522 awarded for that fiscal year; activity R44 (SBIR); PI OSTLAND, VAUGHN E; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Novel Point-of-Care Device for Urin source ↗
Feb 27, 2018 NIH award 5R44DK113841-02 FY2018: $676,117 awarded for that fiscal year; activity R44 (SBIR); PI OSTLAND, VAUGHN E; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Monoclonal Sandwich ELISA for Serum source ↗
Mar 6, 2017 NIH award 1R44DK113841-01 FY2017: $810,487 awarded for that fiscal year; activity R44 (SBIR); PI OSTLAND, VAUGHN E; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Monoclonal Sandwich ELISA for Serum source ↗
Sep 12, 2016 NIH award 3R44DK083843-06S1 FY2016: $181,804 awarded for that fiscal year; activity R44 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. supplemental funding for Pha source ↗
Mar 22, 2016 NIH award 5R44DK083843-06 FY2016: $1,368,932 awarded for that fiscal year; activity R44 (SBIR); PI OSTLAND, VAUGHN E; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Serum Hepcidin Immunoassay: Labor source ↗
Feb 27, 2015 NIH award 5R44DK083843-05 FY2015: $1,391,549 awarded for that fiscal year; activity R44 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Serum Hepcidin Immunoassay: source ↗
Apr 17, 2014 NIH award 5R43DK096878-02 FY2014: $335,886 awarded for that fiscal year; activity R43 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Hepcidin Lateral Flow Device f source ↗
Apr 10, 2014 NIH award 2R44DK083843-04 FY2014: $1,465,629 awarded for that fiscal year; activity R44 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Serum Hepcidin Immunoassay: source ↗
Mar 29, 2013 NIH award 1R43DK096878-01A1 FY2013: $364,451 awarded for that fiscal year; activity R43 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Hepcidin Lateral Flow Device source ↗
Mar 6, 2012 NIH award 5R44DK083843-03 FY2012: $655,132 awarded for that fiscal year; activity R44 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Serum Hepcidin Immunoassay: La source ↗
Mar 29, 2011 NIH award 2R44DK083843-02 FY2011: $631,188 awarded for that fiscal year; activity R44 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Serum Hepcidin Immunoassay: La source ↗
Sep 11, 2009 NIH award 1R43DK083843-01A1 FY2009: $356,360 awarded for that fiscal year; activity R43 (SBIR); PI WESTERMAN, MARK EDWARD; recipient as written: INTRINSIC LIFESCIENCES, LLC, LA JOLLA, CA. Serum Hepcidin Immunoassay: source ↗